SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Relmada Therapeutics, Inc. (RLMD) News

Track canonical SquawkNews coverage tagged to RLMD, Relmada Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol RLMD Asset equity Sector Markets 90 days 1 Last 4.8 Updated Jun 18, 2026, 10:55 AM UTC Open live news feed
M RLMD: HC Wainwright Initiates Buy HC Wainwright & Co. initiates coverage on Relmada Therapeutics with a buy rating and a price target of $12 EQUITY | Jun 18, 2026, 10:55 AM UTC